World Health Organization. Cardiovascular diseases (CVDs) fact sheets. 2021.
Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–44. doi: https://doi.org/10.1161/CIR.0b013e31820a55f5.
O’Donnell MJ, Chin SL, Rangarajan S, Xavier D, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016;388(10046):761–75. doi: https://doi.org/10.1016/s0140-6736(16)30506-2.
Global regional. and national burden of stroke and its risk factors, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. doi: https://doi.org/10.1016/s1474-4422(21)00252-0.
Goldstein LB. Introduction for Focused Updates in Cerebrovascular Disease. Stroke. 2020;51(3):708–10. doi: https://doi.org/10.1161/strokeaha.119.024159.
Ormazabal V, Nair S, Elfeky O, Aguayo C, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122. doi: https://doi.org/10.1186/s12933-018-0762-4.
Article CAS PubMed PubMed Central Google Scholar
Bressler P, Bailey SR, Matsuda M, DeFronzo RA. Insulin resistance and coronary artery disease. Diabetologia. 1996;39(11):1345–50. doi: https://doi.org/10.1007/s001250050581.
Article CAS PubMed Google Scholar
Di Pino A, DeFronzo RA. Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents. Endocr Rev. 2019;40(6):1447–67. doi: https://doi.org/10.1210/er.2018-00141.
Article PubMed PubMed Central Google Scholar
Kraemer FB, Ginsberg HN. Gerald M, Reaven MD. Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease. Diabetes Care. 2014;37(5):1178–81. doi: https://doi.org/10.2337/dc13-2668.
Wang A, Wang G, Liu Q, Zuo Y, et al. Triglyceride-glucose index and the risk of stroke and its subtypes in the general population: an 11-year follow-up. Cardiovasc Diabetol. 2021;20(1):46. doi: https://doi.org/10.1186/s12933-021-01238-1.
Article CAS PubMed PubMed Central Google Scholar
Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol metabolism. 2008;294(1):E15–26. doi: https://doi.org/10.1152/ajpendo.00645.2007.
Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–95. doi: https://doi.org/10.2337/diacare.27.6.1487.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9. doi: https://doi.org/10.1007/bf00280883.
Article CAS PubMed Google Scholar
Vasques AC, Novaes FS, de Oliveira Mda S, Souza JR, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–100. doi: https://doi.org/10.1016/j.diabres.2011.05.030.
Article CAS PubMed Google Scholar
Zhao Q, Zhang TY, Cheng YJ, Ma Y, et al. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol. 2020;19(1):108. doi: https://doi.org/10.1186/s12933-020-01086-5.
Article CAS PubMed PubMed Central Google Scholar
Irace C, Carallo C, Scavelli FB, De Franceschi MS, et al. Markers of insulin resistance and carotid atherosclerosis. A comparison of the homeostasis model assessment and triglyceride glucose index. Int J Clin Pract. 2013;67(7):665–72. doi: https://doi.org/10.1111/ijcp.12124.
Article CAS PubMed Google Scholar
Luo JW, Duan WH, Yu YQ, Song L, et al. Prognostic significance of triglyceride-glucose index for adverse cardiovascular events in patients With coronary artery disease: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:774781. doi: https://doi.org/10.3389/fcvm.2021.774781.
Article CAS PubMed PubMed Central Google Scholar
Zhao S, Yu S, Chi C, Fan X, et al. Association between macro- and microvascular damage and the triglyceride glucose index in community-dwelling elderly individuals: the Northern Shanghai Study. Cardiovasc Diabetol. 2019;18(1):95. doi: https://doi.org/10.1186/s12933-019-0898-x.
Article CAS PubMed PubMed Central Google Scholar
Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana-Delgado J, et al. The TyG index may predict the development of cardiovascular events. Eur J Clin Invest. 2016;46(2):189–97. doi: https://doi.org/10.1111/eci.12583.
Article CAS PubMed Google Scholar
Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. doi: https://doi.org/10.1371/journal.pmed.1000097.
Article PubMed PubMed Central Google Scholar
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5. doi: https://doi.org/10.1007/s10654-010-9491-z.
Guyatt GH, Oxman AD, Vist GE, Kunz R, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj. 2008;336(7650):924–6. doi: https://doi.org/10.1136/bmj.39489.470347.AD.
Article PubMed PubMed Central Google Scholar
Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10:101–29.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003;327(7414):557–60. doi: https://doi.org/10.1136/bmj.327.7414.557.
Article PubMed PubMed Central Google Scholar
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Bmj. 1997;315(7109):629–34. doi: https://doi.org/10.1136/bmj.315.7109.629.
Article CAS PubMed PubMed Central Google Scholar
Palmer TM, Peters AJS,JL. and S. G. Moreno. Contour-enhanced funnel plots for meta-analysis. Stata J. 2008;8(2):242–54.
Zhao Q, Zhang TY, Cheng YJ, Ma Y, et al. Triglyceride-glucose index as a surrogate marker of insulin resistance for predicting cardiovascular outcomes in nondiabetic patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. J atherosclerosis Thromb. 2021;28(11):1175–94. doi: https://doi.org/10.5551/jat.59840.
Mao Q, Zhou D, Li Y, Wang Y, et al. The Triglyceride-glucose index predicts coronary artery disease severity and cardiovascular outcomes in patients with non-st-segment elevation acute coronary syndrome. Disease markers 2019; : 6891537. doi: https://doi.org/10.1155/2019/6891537.
Li S, Guo B, Chen H, Shi Z, et al. The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis. Sci Rep. 2019;9(1):7320. doi: https://doi.org/10.1038/s41598-019-43776-5.
Article CAS PubMed PubMed Central Google Scholar
Wang A, Tian X, Zuo Y, Chen S, et al. Change in triglyceride-glucose index predicts the risk of cardiovascular disease in the general population: a prospective cohort study. Cardiovasc Diabetol. 2021;20(1):113. doi: https://doi.org/10.1186/s12933-021-01305-7.
Article CAS PubMed PubMed Central Google Scholar
Liu Q, Cui H, Ma Y, Han X, et al. Triglyceride-glucose index associated with the risk of cardiovascular disease: the Kailuan study. Endocrine. 2022;75(2):392–9. doi: https://doi.org/10.1007/s12020-021-02862-3.
Article CAS PubMed Google Scholar
Hong S, Han K, Park CY. The insulin resistance by triglyceride glucose index and risk for dementia: population-based study. Alzheimer’s Res therapy. 2021;13(1):9. doi: https://doi.org/10.1186/s13195-020-00758-4.
Zhao Y, Sun H, Zhang W, Xi Y, et al. Elevated triglyceride-glucose index predicts risk of incident ischaemic stroke: The Rural Chinese cohort study. Diabetes & metabolism. 2021;47(4):101246. doi: https://doi.org/10.1016/j.diabet.2021.101246.
Kim J, Shin SJ, Kang HT. The association between triglyceride-glucose index, cardio-cerebrovascular diseases, and death in Korean adults: A retrospective study based on the NHIS-HEALS cohort. PLoS One. 2021;16(11):e0259212. doi: https://doi.org/10.1371/journal.pone.0259212.
Article CAS PubMed PubMed Central Google Scholar
Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361. doi: https://doi.org/10.1186/s12916-020-01824-2.
Article CAS PubMed PubMed Central Google Scholar
Wu Z, Wang J, Li Z, Han Z, et al. Triglyceride glucose index and carotid atherosclerosis incidence in the Chinese population: A prospective cohort study. Nutr metabolism Cardiovasc diseases: NMCD. 2021;31(7):2042–50. doi: https://doi.org/10.1016/j.numecd.2021.03.027.
Article CAS PubMed Google Scholar
Wang L, Cong HL, Zhang JX, Hu YC, et al. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome. Cardiovasc Diabetol. 2020;19(1):80. doi: https://doi.org/10.1186/s12933-020-01054-z.
留言 (0)